Keyphrases
Cuban
100%
Cost-plus
100%
Drug Companies
100%
Medicare
93%
Clinical Trials
34%
Medicare Part D
32%
Drug Costs
26%
Drug Development
23%
Cost-savings Potential
20%
Affordable Solution
20%
Trametinib
20%
Dabrafenib
20%
Risk Outcomes
20%
Patient Outcomes
20%
Risk-benefit
20%
Patient Benefit
20%
Anxiety Disorders
20%
Core Outcome Set
20%
Orthopedics
20%
Diabetes Medications
20%
Trialists
20%
Web-based Survey
20%
Seizure
20%
Medicaid
20%
Patient Risk
20%
Mixed Methods Evaluation
20%
Dear Editor
20%
Men's Health
20%
Potential Savings
19%
Cost Savings
18%
Accelerated Approval
13%
Medicare Spending
9%
Spending Data
9%
Unit Price
9%
Cost Difference
8%
Sectional Analysis
8%
Potential Cost Savings
7%
Healthcare Expenditure
7%
Prescription Drugs
7%
Dispensing Fees
7%
BRAFV600
6%
Health Care Costs
6%
Malignancy
6%
Financial Burden
6%
Cumulative Costs
6%
Minimum Quantity
5%
Shipping Fees
5%
Unit Cost
5%
Total Saving
5%
Company Website
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cross Sectional Study
42%
Drug Development
40%
Prescription Medication
40%
Clinical Trial
37%
Prescription Drug
30%
Chronicity
20%
Trametinib
20%
Dabrafenib
20%
Myositis
20%
Muscle Relaxant Agent
20%
Myalgia
20%
Anxiety Disorder
20%
Fluticasone Propionate
20%
Drug Analysis
20%
Metformin
20%
Tablet
20%
Atopic Dermatitis
20%
Anticonvulsive Agent
20%
Disease
20%
Diabetes Mellitus
20%
Gout
20%
Inflammation
20%
Drug Screening
12%
Generic Drug
10%
Prevalence
10%
